Given that Cyclin C depleted cells had reduced basal levels of DNA:RNA hybrids, correlating with reduced ATRi/CHK1i-induced hybrid formation, it is possible that basal DNA:RNA hybrid levels could be used as a phenotypic biomarker in patient tumour samples to predict ATR and CHK1 inhibitor efficacy. Here, ATR is linked to neoplasm.